Research beacons: Cancer
16 Feb 2015
The University's approach to cancer research spans the full spectrum of combating the disease
Our research beacons showcase areas where our researchers work with colleagues from across the University and beyond to produce solutions that are distinct to Manchester.
World-class research is the first goal of our Manchester 2020 strategy. Our aim is to be among the top 25 research universities in the world by 2020.
This week, we look at how our cancer experts are committed to the full spectrum of combatting cancer, from understanding the molecular and cellular basis of cancer to the development and testing of novel drugs and other therapeutic approaches.
Through our nursing, psychology and policy work, we’re researching and putting into practice solutions to cancer’s physical, emotional and economic impact. And our collaborations with companies like AstraZeneca and GlaxoSmithKline bring new drugs to the market more quickly.
Our partnerships make for an unrivalled beacon of research, where outstanding clinical work is leading to new techniques and innovative personalised treatments. We work closely with the NHS and have strong links with charities including Cancer Research UK, giving us access to funds and equipment that place us at the forefront of cancer treatment.